Ventolin

DRUG4 trials

Sponsors

Chiesi Farmaceutici S.p.A., Laval University, Shanghai Biomabs Pharmaceutical Co., Ltd., Ziauddin University

Conditions

AsthmaAsthma, AllergicStatus Asthmaticus

Phase 1

Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus

CompletedNCT04929626

Ziauddin UniversityStatus Asthmaticus

Start: 2022-01-01End: 2022-11-12Updated: 2023-04-05

Phase 3

Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics

CompletedNCT00861926

Chiesi Farmaceutici S.p.A.Asthma

Start: 2009-03-31End: 2011-04-30Updated: 2017-03-30

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

CompletedNCT03468790

Shanghai Biomabs Pharmaceutical Co., Ltd.Asthma, Allergic

Start: 2018-05-09End: 2021-03-09Updated: 2021-10-11

Unknown Phase

Role of Airway Hyperresponsiveness on Performance in Elite Swimmers.

CompletedNCT00876135

Laval UniversityAsthma

Start: 2008-12-31End: 2013-05-31Updated: 2013-05-13

Related Papers

Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial.

2025-11-26

Comparison of doses of Nebulized Magnesium sulphate as an adjuvant treatment with salbutamol in children with Status Asthmaticus

Pakistan Journal of Medical Sciences2024-03-185 citations

Symptoms and exacerbations in asthma: an apparent paradox?

Therapeutic Advances in Chronic Disease2019-01-016 citations

Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.

2013-03-04107 citations